Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies ; volume:14 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-10 ; date:12.2024
Blood cancer journal ; 14, Heft 1 (3.12.2024), 1-10, 12.2024
- Creator
-
Tao, Zhongfei
Chyra, Zuzana
Kotulová, Jana
Celichowski, Piotr
Mihályová, Jana
Charvátová, Sandra
Hájek, Roman
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-024-01193-6
- URN
-
urn:nbn:de:101:1-2502172129567.584594531533
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tao, Zhongfei
- Chyra, Zuzana
- Kotulová, Jana
- Celichowski, Piotr
- Mihályová, Jana
- Charvátová, Sandra
- Hájek, Roman
- SpringerLink (Online service)
Other Objects (12)
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
Special issue: CAR‐T cell therapy for hematological malignancies
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Recent updates on allogeneic CAR-T cells in hematological malignancies
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Superior anti-tumor efficacy of CD4⁺ CAR-T cells in hematological malignancies
The journey of CAR-T therapy in hematological malignancies
CAR-T cell combination therapies in hematologic malignancies
The Application of CAR-T Cells in Haematological Malignancies
Adoptive therapy with CAR redirected T cells for hematological malignancies
Engineering CAR-T cells
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies